Raymond James & Associates’s Zentalis Pharmaceuticals ZNTL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q3	$58.4K	Buy	15,865 +4,626	+41%	+$17K	﹤0.01%	3790
2024 Q2	$46K	Sell	11,239 -874	-7%	-$3.58K	﹤0.01%	3758
2024 Q1	$191K	Buy	+12,113	New	+$191K	﹤0.01%	3598